BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

Health professional touching screen, digital/medical icons

PwC focuses on how digital transformation in health care will impact consumers

Dec. 30, 2019
By Liz Hollis
Will the digital transformation in health care start to benefit consumers in 2020? That was one of the challenges addressed in a recent report from PwC Health Research Institute titled “Top health industry issues of 2020: Will digital start to show an ROI?” The report predicts that in the next year, health system leaders will tout their investments in technology and transformation.
Read More

Biggest gainers and losers for the week of Dec. 23-27, 2019

Dec. 27, 2019
The top 10 biopharma stock gainers and losers for the week.
Read More
Speech bubbles
Best of 'Word on the Street' part 2

Perspectives on the year: The industry has its say on scientific breakthroughs and ongoing policy sagas

Dec. 27, 2019
By Peter Winter
Throughout the year we have published the views of company executives, government regulators, industry analysts and scientists on a variety of topics and, in our popular annual feature, we include a selection of these that paints a picture of the significant events that shaped 2019.
Read More

Completed biopharmaceutical mergers & acquisitions: September 2019

Dec. 27, 2019
Completed biopharma mergers and acquisitions in September 2019.
Read More

Completed biopharmaceutical mergers & acquisitions: October 2019

Dec. 27, 2019
Completed biopharma mergers and acquisitions in October 2019.
Read More

Completed biopharmaceutical mergers & acquisitions: November 2019

Dec. 27, 2019
Completed biopharma mergers and acquisitions in November 2019.
Read More

Biopharmaceutical collaborations: November 2019

Dec. 27, 2019
Biopharma licensings, joint ventures and collaborations in November 2019.
Read More

Money raised by biopharma: 2019 vs. 2018

Dec. 27, 2019
Total raised in public, private and other financings of biopharma companies, comparing 2019 vs. 2018.
Read More

Biopharma money raised: Jan. 1-Dec. 20, 2019

Dec. 27, 2019
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More
Speech bubbles
Best of 'Word on the Street' part 1

Perspectives on the year: The industry has its say on the markets, M&A and gene therapy

Dec. 24, 2019
By Peter Winter
Throughout the year we have published the views of company executives, government regulators, industry analysts and scientists on a variety of topics and, in our popular annual feature, we include a selection of these that paints a picture of the significant events that shaped 2019. The major talking point was on the capital markets front where investors turned their backs on the biopharmaceutical sector for most of the year returned big time in the final quarter.
Read More
Previous 1 2 … 280 281 282 283 284 285 286 287 288 … 299 300 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 12, 2025.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing